Site icon Impactiviti

Impactiviti Daily 051210 Top Pharma News

*****
TODAY’S NEWS

Sanofi taking a heavy dice-roll on Multaq: 11,000-patient trial on expanded use.

A glimpse into Merck‘s late-stage pipeline. Very diverse group of molecules and conditions. Here’s an interesting little extra on the cholesterol drug.

FDA launches 1-800-TATTLE: The FDA is asking healthcare professionals to keep an eye out for violative promotion and to call 1-877-RX-DDMAC or emailing badad@fda.com when they see itmore

Pfizer: NYC layoffs and relos, plus selling a midtown building. And, late-breaking, Takeda also embarking on major cuts.

The VA about to tighten the rules on drug sales rep interactions. Part of a nationwide trend.

RECOMMENDED

Management Training. The Impactiviti network can help you with all your needs for training managers, finding the optimal suppliers for you. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

So…who’s been doing the best Social Media in Pharma? The new Dosie Award winners were announced live at the BDI Social Communications in Healthcare event yesterday.

JUST FOR FUN

Sunsets. Nice.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Visit the Impactiviti Job Board

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

*****

Exit mobile version